| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3325941 | NPG Neurologie - Psychiatrie - Gériatrie | 2016 | 8 Pages |
Abstract
This study explored of the use of AD biomarker measures in clinical practice. While their implementation is currently focused on the diagnosis of AD at a mild stage, these biomarkers showed their usefulness in situations where the clinical diagnosis is made difficult by a psychiatric disorder and/or delirium, or when neuropsychological investigations are unfeasible.
Related Topics
Health Sciences
Medicine and Dentistry
Geriatrics and Gerontology
Authors
F. Weill, M. Kiesmann, O. Bousiges, C. Trivalle, T. Vogel, G. Kaltenbach, P.-O. Lang,